QuVa Pharma Methohexital Sodium Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
QuVa Pharma, Inc. is recalling multiple lots of Methohexital Sodium after the product failed impurities and degradation specifications.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
QuVa Pharma, Inc. initiated a voluntary recall of Methohexital Sodium due to failed impurities/degradation specifications.
Which Products Are Affected
The affected product is Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46. Distribution is nationwide within the United States. Affected lots include: 10162261, 10162262, 10162279, 10162280 (Exp. Date 07/21/2026); 10162314, 10162315 (Exp. Date 07/22/2026); 10162465, 10162466, 10162491, 10162492 (Exp. Date 07/26/2026); 10162542, 10162543 (Exp. Date 07/27/2026); 10162559, 10162560 (Exp. Date 07/28/2026); 10162623, 10162624 (Exp. Date 07/29/2026); 10162693, 10162694 (Exp. Date 07/30/2026); 10162735, 10162736, 10162753, 10162754 (Exp. Date 07/31/2026); 10162772, 10162773, 10162791, 10162792, 10162810, 10162811 (Exp. Date 08/02/2026); 10162820 (Exp. Date 08/03/2026); 10162853, 10162854 (Exp. Date 08/04/2026); 10163046 (Exp. Date 08/09/2026); 10163156, 10163157 (Exp. Date 08/10/2026). Recall number: D-0664-2026. Classification: Class II. Status: Ongoing.
What You Should Do
Consumers should consult the recalling firm or their healthcare provider regarding the recalled product.
Why This Matters
The recall affects compounded Methohexital Sodium distributed nationwide.
Source
FDA recall D-0664-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,426 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.